Found: 5
Select item for more details and to access through your institution.
Effect of hepatic or renal impairment on the pharmacokinetics of casopitant, a NK-1 receptor antagonist.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 2, p. 662, doi. 10.1007/s10637-010-9604-2
- By:
- Publication type:
- Article
Effect of casopitant, a novel NK-1 antagonist, on the pharmacokinetics of dolasetron and granisetron.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Ketoconazole and Rifampin Significantly Affect the Pharmacokinetics, But Not the Safety or QTc Interval, of Casopitant, a Neurokinin-1 Receptor Antagonist.
- Published in:
- Journal of Clinical Pharmacology, 2010, v. 50, n. 8, p. 951, doi. 10.1177/0091270009353761
- By:
- Publication type:
- Article
Effect of Casopitant, a Novel NK-1 Receptor Antagonist, on the Pharmacokinetics and Pharmacodynamics of Steady-State Warfarin.
- Published in:
- Journal of Clinical Pharmacology, 2010, v. 50, n. 5, p. 566, doi. 10.1177/0091270009346965
- By:
- Publication type:
- Article
ASCT2-Targeting Antibody-Drug Conjugate MEDI7247 in Adult Patients with Relapsed/Refractory Hematological Malignancies: A First-in-Human, Phase 1 Study.
- Published in:
- Targeted Oncology, 2024, v. 19, n. 3, p. 321, doi. 10.1007/s11523-024-01054-z
- By:
- Publication type:
- Article